Organisation paid for research Program year 2025 Source: CMS Open Payments

Saltzer Medical Group

Neither a doctor nor a teaching hospital

Research payments

$1,326,559

589 payments

Through program year 2025, Saltzer Medical Group is reported as receiving $1,326,559 in research payments, across 589 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$2,500	1
2024	Research	$50,816	17
2023	Research	$207,556	40
2022	Research	$288,174	110
2021	Research	$420,624	139
2020	Research	$200,932	168
2019	Research	$155,958	114

Breakdown

Who paid Research payments · program years 2019–2025

GlaxoSmithKline, LLC. $709,319 323 payments
Merck Sharp & Dohme Corporation $527,797 117 payments
Jazz Pharmaceuticals Inc. $44,005 18 payments
Novo Nordisk AS $33,188 127 payments
Pfizer Inc. $12,250 4 payments

Studies the money was for Research payments · program years 2019–2025

Study name not reported $320,972 130 payments
A Phase 3, Multicenter, Randomized, Double-blind, Active-Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of a 4-dose Regimen of V114 in Healthy Infants PNEU-PED $243,957 22 payments
A Phase 2b,3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants $226,781 12 payments
Phase 3B, Randomized, Observer-Blind. Multicenter Study to Assess the $110,148 23 payments
A Phase III, Randomized, Controlled, Observer-Blind Study to Demonstra $70,940 50 payments
A Phase III, Randomized, Double-Blind, Placebo-Controlled Multi-Countr $70,874 46 payments
Menb Rec 2Nd Gen-023 (V72_57) $65,702 44 payments
Nn9535-4321 $33,188 127 payments
A Phase III Clinical Trial to Study the Immunogenicity, Tolerability, and Manufacturing Consistency of V503 A Multivalent Human Papillomavirus HPV L1 Virus-Like Particle VLP Vaccine in Preadolescents and Adolescents 9 to 15 year olds with a Comparison to Young Women 16 to 26 year olds $31,853 6 payments
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to Xywav $25,145 12 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.